NEUNEUREN PHARMACEUTICALS LIMITEDMarket sensitive

Trofinetide US patent protections extended to March 2041

Date and time
Announcement type
Company Update

More from Health Care

RGTCompany Update29 September 2026

Argent BioPharma (ASX: RGT) Licences NLC Antiviral Portfolio

More News